Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The INR: a perspective

R E Smith1

  • 1Allegheny University of Health Sciences, Pittsburgh, Pennsylvania, USA.

Seminars in Thrombosis and Hemostasis
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

The International Normalized Ratio (INR) standardizes prothrombin time tests for oral anticoagulant therapy. This study explains INR development, its limitations, and how to address common misinterpretations for safer patient monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal hematoma and tear requiring emergency surgical intervention. A case report and literature review.

Digestive diseases and sciences·1992
Same author

Introduction of a partial shift system for house officers in a teaching hospital.

BMJ (Clinical research ed.)·1992
Same author

Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study.

Ophthalmology·1992
Same author

The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV.

The Histochemical journal·1992
Same author

Cardiac doses in post-operative breast irradiation.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1992
Same author

Amplification of doxorubicin mutagenicity by cupric ion.

Toxicology and applied pharmacology·1992
Same journal

Full- vs Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
Same journal

Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department.

Seminars in thrombosis and hemostasis·2026
Same journal

Acute Management and Bleeding Outcomes in Pediatric Pulmonary Embolism: A Large Single-Center Retrospective Cohort Study.

Seminars in thrombosis and hemostasis·2026
Same journal

Red Blood Cells in Hemostasis and Thrombosis: Mechanisms, Interactions, and Clinical Implications.

Seminars in thrombosis and hemostasis·2026
Same journal

Pediatric Pulmonary Infarction and Infarction-Like Pulmonary Injury: An Etiology-Oriented Narrative Review.

Seminars in thrombosis and hemostasis·2026
Same journal

Comparison of the Coagulation Profile Following Treatment of Major Surgical Haemorrhage with Fresh Frozen Plasma or Fibrinogen Concentrate.

Seminars in thrombosis and hemostasis·2026
See all related articles

Area of Science:

  • Medical Science
  • Clinical Pathology
  • Pharmacology

Background:

  • Oral anticoagulants are crucial for treating and preventing thromboembolic disease.
  • Prothrombin time (PT) monitoring is essential for safe and effective oral anticoagulant therapy.
  • Variability in PT measurements between laboratories complicates patient management.

Purpose of the Study:

  • To explain the necessity and evolution of the International Normalized Ratio (INR).
  • To critically examine the limitations and frequent misinterpretations associated with the INR.
  • To provide practical solutions for overcoming the identified shortcomings of the INR.

Main Methods:

  • Literature review on the development and application of PT and INR.
  • Analysis of common errors and misinterpretations in INR reporting and usage.

Related Experiment Videos

  • Development of practical recommendations for accurate INR interpretation and application.

    • Main Results:

    • The INR was developed to standardize PT measurements globally.
    • Significant inter-laboratory variability and misinterpretations of INR persist.
    • Specific strategies can mitigate the impact of INR shortcomings.

    Conclusions:

    • Standardization of PT via INR is vital for oral anticoagulant therapy.
    • Addressing INR limitations is crucial for improving patient safety and therapeutic outcomes.
    • Implementing corrected approaches enhances the reliability of INR in clinical practice.